MIP Technologies AB

MIP Technologies is an innovative biotechnology company working at the boundary between chemistry and material science. The Company uses innovative proprietary technology based on molecularly imprinted polymers for the development of separation and extraction products. In addition to unique know-how and intellectual property, the company has developed a technology platform enabling a rapid and economic development of custom made Separation Phases with superior properties. MIP Technologies, founded in 2000, is the pioneer in commercial applications of molecular imprinting. It was founded by researchers from the European Research Network, MICA (Molecular Imprinting in Chemical Analysis) and has a strategic relationship with Professor Börje Sellergren at the University of Dortmund for cutting-edge research. MIP Technologies is located in Lund, Sweden, and has 17 employees.

The privately held Company is owned by Teknoseed, Malmöhus Invest, Catella Healthcare Investment, founders and management. The Company completed a SEK 30 M financing round, with Catella Healthcare Investments as lead investor, in August 2005.